Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Share-based Compensation: 2009-2025

Historic Share-based Compensation for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $1.8 million.

  • Prestige Consumer Healthcare's Share-based Compensation fell 17.20% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of $11.2 million for FY2025, which is 20.36% down from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Share-based Compensation stood at $1.8 million, which was down 52.01% from $3.7 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Share-based Compensation high stood at $4.1 million for Q2 2023, and its period low was $1.7 million during Q1 2022.
  • Over the past 3 years, Prestige Consumer Healthcare's median Share-based Compensation value was $2.9 million (recorded in 2024), while the average stood at $3.0 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Share-based Compensation soared by 105.38% in 2022 and then tumbled by 42.14% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Share-based Compensation (Quarterly) stood at $2.2 million in 2021, then grew by 8.91% to $2.4 million in 2022, then increased by 0.66% to $2.4 million in 2023, then grew by 16.99% to $2.9 million in 2024, then declined by 17.20% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $3.7 million for Q2 2025, and $2.7 million during Q1 2025.